Patients News | pharmaphorum

Saturday 7 February 2026

News

News

Daniel Nadler, co-founder and chief executive of OpenEvidence

Medical chatbot firm OpenEvidence raises $210m

OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.

News

NICE relents and backs Kisqali for wide use in breast cancer

NICE relents and backs Kisqali for wide use in breast cancer

Novartis' breast cancer therapy Kisqali has been cleared for NHS use in early breast cancer, an indication driving blockbuster sales of the drug.

News

Colleagues discuss information on a laptop screen

EVERSANA unveils new AI-powered pharmacovigilance suite

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

News

Digital scan of kidneys

NHS trust rolls out digital health tool for kidney disease

An NHS trust in England is starting a pilot study of a digital health platform that promises to improve the care of people with kidney disease.

News

HCP with dose of PrEP

Gilead's twice-yearly HIV PrEP set for wider rollout

The WHO has recommended Gilead's twice-yearly HIV PrEP drug lenacapavir, calling it 'transformational', but there are concerns about patient access.

News

Woman looks at screen with imaging scan details

UK Biobank charts success of NHS imaging project

The UK Biobank has completed the world's largest whole body imaging project, compiling more than a billion scans from 100,000 volunteers.